Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (GB:0JZU)
LSE:0JZU
Holding GB:0JZU?
Track your performance easily
0JZU Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$431.28 - $636.44
Previous Close$476.72
Volume401.00
Average Volume (3M)542.00
Market Cap
$62.13B
Enterprise Value$67.60B
Total Cash (Recent Filing)$2.30B
Total Debt (Recent Filing)$7.40B
Price to Earnings (P/E)21.3
Beta0.35
Next Earnings
Nov 06, 2024EPS Estimate
$7.02Last Dividend Ex-Date
Aug 30, 2024Dividend Yield0.53%
Share Statistics
EPS (TTM)22.36
Shares Outstanding129,676,762
10 Day Avg. Volume448
30 Day Avg. Volume542
Standard Deviation0.06
R-Squared0.09
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-35.59
Price to Sales (P/S)0.20
Price to Cash Flow (P/CF)-11.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.22
Enterprise Value/Gross Profit5.27
Enterprise Value/Ebitda14.14
Forecast
1Y Price Target
$618.00Price Target Upside29.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
McKesson News
Bulls Say, Bears Say
Bulls Say
AcquisitionsMcKesson announced its acquisition of Florida Cancer Specialists, which added an estimated $3.6Bn of oncology spend to McKesson’s platform.
Operational FocusAn increased operational focus on the US businesses (Pharma, RxTS, Med/Surg) is a positive.
Strategic FocusMcKesson’s decision to prioritize investment in faster growing areas like oncology and biopharma services is a positive.
Bears Say
Earnings GuidanceA bigger fear is that MCK could use this meeting as an opportunity to bring down its longer-term EPS growth guidance, which is viewed as meaningfully ahead of its peers on a like-for-like basis.
Financial PerformanceMcKesson missed FY4Q24 operationally on multiple fronts, then followed up with an even worse FY1Q25 that included negative revenue and AOI variances in US Pharma, Med-Surg, and Prescription Tech, with several negative operating guidance adjustments.
Transparency IssuesGuidance and explanations feel 'off' recently, particularly what’s happening in Med Surg and Prescription Tech, creating further investor frustration.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.56% Insiders
23.91% Mutual Funds
38.04% Other Institutional Investors
37.49% Public Companies and
Individual Investors
0JZU FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest share price was $431.28 and its highest was $636.44 in the past 12 months.
What is Mckesson Corp.’s market cap?
Currently, no data Available
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Nov 06, 2024 which is in 41 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Aug 07, 2024. The company reported $7.88 earnings per share for the quarter, beating the consensus estimate of $7.209 by $0.671.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.71 which represents an annual dividend yield of 0.53%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is $7.02.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 129,676,760 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $7.88 in its last earnings report, beating expectations of $7.209. Following the earnings report the stock price went down -12.232%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Among the largest hedge funds holding Mckesson Corp.’s share is Lone Pine Capital LLC. It holds Mckesson Corp.’s shares valued at 328M.
---
McKesson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$618.00 (29.64% Upside)
$618.00 (29.64% Upside)
Blogger Sentiment
Bullish
GB:0JZU Sentiment 92%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
11.82%
Trailing 12-Months
Company Description
Mckesson Corp.
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
---
0JZU Company Deck
---
0JZU Earnings Call
Q1 2024
0:00 / 0:00
---
0JZU Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
---
0JZU Stock 12 Month Forecast
Average Price Target
$618.00
▲(29.64% Upside)
Technical Analysis
McKesson
―
Cardinal Health
―
CVS Health
―
GoodRx Holdings
―
Walgreens Boots Alliance
―
Best Analysts Covering 0JZU
1 Year
1 Year Success Rate
16/20 ratings generated profit
1 Year Average Return
+27.50%
reiterated a buy rating 5 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +27.50% per trade.
---